|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500101231 |
|
最近更新日期: Date of Last Refreshed on: |
2025-04-22 11:35:21 |
|
注册时间: Date of Registration: |
2025-04-22 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
中国女性妇科门诊患者VVC菌种及发病危险因素的多中心流行病学研究 |
|
Public title: |
A multicenter epidemiological study of VVC strains and risk factors in Chinese female gynecological outpatients |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
中国女性妇科门诊患者VVC菌种及发病危险因素的多中心流行病学研究 |
|
Scientific title: |
A multicenter epidemiological study of VVC strains and risk factors in Chinese female gynecological outpatients |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
曾桢 |
研究负责人: |
廖秦平 |
|
Applicant: |
Zhen Zeng |
Study leader: |
Qinping Liao |
|
申请注册联系人电话: Applicant telephone: |
+86 134 6654 4279 |
研究负责人电话:
Study leader's |
+86 137 0112 4527 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zza02617@btch.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
lqpa00594@btch.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
北京清华长庚医院 |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
北京市昌平区立汤路168号 |
研究负责人通讯地址: |
北京市昌平区立汤路168号 |
|
Applicant address: |
No. 168, Litang Road, Changping District, Beijing |
Study leader's address: |
No. 168, Litang Road, Changping District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
102218 |
研究负责人邮政编码: Study leader's postcode: |
102218 |
|
申请人所在单位: |
北京清华长庚医院 |
||
|
Applicant's institution: |
Beijing Tsinghua Changgung Hospital |
||
|
研究负责人所在单位: |
北京清华长庚医院 |
||
|
Affiliation of the Leader: |
Beijing Tsinghua Changgung Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
23683-4-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
北京清华长庚医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Beijing Tsinghua Changgung Hospital Medical Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-12-12 00:00:00 | ||
|
伦理委员会联系人: |
刘曼婷 |
||
|
Contact Name of the ethic committee: |
Manting Liu |
||
|
伦理委员会联系地址: |
北京市昌平区立汤路168号 |
||
|
Contact Address of the ethic committee: |
No. 168, Litang Road, Changping District, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 10 5611 8567 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
北京清华长庚医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Beijing Tsinghua Changgung Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市昌平区立汤路168号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 168, Litang Road, Changping District, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
江苏恒瑞医药股份有限公司 |
||||||||||||||||||||||
|
Source(s) of funding: |
Jiangsu Hengrui Pharmaceuticals Co.,Ltd |
||||||||||||||||||||||
|
研究疾病: |
外阴阴道假丝酵母菌病 |
||||||||||||||||||||||
|
Target disease: |
Vulvovaginal candidiasis |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
1.主要目的:全国范围内妇科门诊就诊VVC患者菌种组成和分布 2.次要目的: (1)全国范围内妇科门诊就诊VVC患者菌种对常用抗真菌药物药物敏感性及耐药情况分析 (2)全国范围内妇科门诊VVC患者发病危险因素分析 (3)全国范围内妇科门诊VVC患者不同年龄段占比(育龄期和非育龄期)情况分析 (4)全国范围内妇科门诊VVC患者临床诊断和微生物检测确诊的一致性分析 (5)全国范围内妇科门诊各种类型VVC占比情况分析 (6)全国范围内妇科门诊VVC患者的精神神经行为分析 |
||||||||||||||||||||||
|
Objectives of Study: |
1. Main objective: The composition and distribution of VVC patients in gynecological outpatient clinics nationwide 2. Secondary Purpose: (1) Analysis of the susceptibility and resistance of VVC patients in gynecological outpatient clinics to commonly used antifungal drugs nationwide (2) Analysis of risk factors for VVC in gynecological outpatient clinics nationwide (3) Analysis of the proportion of VVC patients of different age groups (childbearing age and non-childbearing age) in gynecological outpatient clinics nationwide (4) Consistency analysis of clinical diagnosis and microbial detection of VVC patients in gynecological outpatient clinics nationwide (5) Analysis of the proportion of various types of VVC in gynecological outpatient clinics nationwide (6) Psychoneurobehavioral analysis of VVC patients in gynecological outpatient clinics nationwide |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.妇科门诊患者 2.年龄>=18周岁 3.自愿签署知情同意书 4.微生物检测诊断为VVC(所有类型VVC均可入组) 5.有性生活史 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Gynecological outpatients 2. Age> = 18 years old 3. Voluntarily sign the informed consent form 4. Diagnosis of VVC by microbial testing (all types of VVC can be enrolled) 5. Have a sexual history |
||||||||||||||||||||||
|
排除标准: |
1.7天内使用过抗真菌药物治疗(口服及阴道上药) 2.存在阴道取样的禁忌症 3.临床医生判断的不适合入组的其他情况 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Antifungal therapy (oral and vaginal) within 7 days 2. Presence of contraindications to vaginal sampling 3. Other conditions judged by the clinician to be unsuitable for enrollment |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-09-01 00:00:00至 To 2026-01-14 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-10-16 00:00:00 至 To 2026-01-14 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
http://www.medresman.org.cn/login.aspx 公开时间:2026年1月,网络公开 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
http://www.medresman.org.cn/login.aspx Open date: January 2026, open online |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF;EDC |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF;EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |